Cart
sales@molnova.com
Trigonelline
CAS No. 535-83-1
Trigonelline( Trigenolline )
Catalog No. M18756 CAS No. 535-83-1
Trigonelline, an alkaloid with potential antidiabetic activity, is present in considerable amounts in coffee.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 30 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 81 | In Stock |
|
| 50MG | 115 | In Stock |
|
| 100MG | 155 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTrigonelline
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrigonelline, an alkaloid with potential antidiabetic activity, is present in considerable amounts in coffee.
-
DescriptionTrigonelline, an alkaloid with potential antidiabetic activity, is present in considerable amounts in coffee.
-
In Vitro——
-
In Vivo——
-
SynonymsTrigenolline
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number535-83-1
-
Formula Weight137.14
-
Molecular FormulaC7H7NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 7.14 mg/mL (52.06 mM)
-
SMILESC[n+]1cccc(c1)C(=O)[O-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ilavenil S, et al. Trigonelline protects the cardiocyte from hydrogen peroxide induced apoptosis in H9c2 cells. Asian Pac J Trop Med. 2015 Apr;8(4):263-8.
molnova catalog
related products
-
1,2-Benzenedicarboxy...
1,2-Benzenedicarboxylic acid is one kind of allelochemical shows stronger allelopathic effect on itself than on wheat and pigeonpea.
-
L319
L319 (Di((Z)-Non-2-en-1-yl) 9-((4-(dimethylamino)butanoyl)oxy)heptadecanedioate) is a lipid membrane, a potential nucleic acid carrier.
-
Berberine sulfate
Berberine sulfate (Berberal) is a quaternary ammonium salt of the benzylisoquinoline alkaloid proto-berberines, which can be used in the study of type 2 diabetes mellitus, abdominal obesity and metabolism-related fatty liver disease.
